|
HS Code |
728799 |
| Product Name | Boc-L-3-Nitrophenylalanine |
| Chemical Formula | C14H18N2O6 |
| Molecular Weight | 310.30 g/mol |
| Cas Number | 127939-49-1 |
| Appearance | White to off-white solid |
| Purity | Typically ≥98% |
| Storage Temperature | 2-8°C |
| Solubility | Soluble in DMSO, DMF; sparingly soluble in water |
| Protecting Group | Boc (tert-butoxycarbonyl) |
| Optical Activity | L-isomer |
| Application | Amino acid for peptide synthesis |
| Functional Groups | Nitro, amino acid, aromatic ring, carbamate |
As an accredited Boc-L-3-Nitrophenylalanine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging for Boc-L-3-Nitrophenylalanine contains 1 gram of white to off-white powder, sealed in a labeled amber glass vial. |
| Shipping | Boc-L-3-Nitrophenylalanine is shipped in secure, airtight containers to prevent moisture and contamination. It is transported in compliance with chemical safety regulations, typically at ambient temperature, unless otherwise specified. Proper labeling and documentation are provided to ensure safe handling during transit. Always refer to the SDS for specific shipping requirements. |
| Storage | Boc-L-3-Nitrophenylalanine should be stored in a cool, dry, and well-ventilated area, away from direct sunlight and sources of heat or ignition. Keep the container tightly closed and protect from moisture. Store at 2-8°C (refrigerator) to maintain stability. Use a chemical storage cabinet if available, and ensure appropriate labeling to prevent accidental misuse or contamination. |
Applications of Boc-L-3-Nitrophenylalanine in Industrial ManufacturingBoc-L-3-Nitrophenylalanine is a specialty protected amino acid used in advanced chemical synthesis, particularly as a building block for high-value molecules in the pharmaceutical, peptide, and research reagent industries. As direct manufacturers, we provide this material to customers strictly for applications where its unique reactivity and ortho-nitro substitution enhance yield, selectivity, or downstream modification during multi-step syntheses. The following sections outline key industrial deployment scenarios, highlighting critical standards, formulation guidelines, integration steps, and the main ready-for-market end-products developed by global downstream partners. 1. Peptide Active Pharmaceutical Ingredient (API) ProductionPeptide drug manufacturers incorporate Boc-L-3-Nitrophenylalanine into custom peptide sequences where aromatic nitro functionality or steric demand at specific positions is required for bioactivity or metabolic stability. Its base-labile Boc protection enables controlled deprotection in solid-phase peptide synthesis (SPPS), yielding high-purity intermediates suited for regulated markets. Our Boc-L-3-Nitrophenylalanine undergoes strict QC for low metal, solvent, and racemization impurities for direct integration into GMP-grade drug programs, typically found in non-standard, difficult peptide constructs where generic raw materials fail. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Pharmaceutical Reference Standard SynthesisAnalytical laboratories producing pharmaceutical reference substances utilize Boc-L-3-Nitrophenylalanine to synthesize validated impurities and isomers for method development, stability testing, and release assays. Its position-specific nitro group provides a unique chromophore for HPLC and MS analysis, while Boc protection allows flexible modification or isotopic labeling. High-purity grade and traceability documentation from source production are mandatory for certified reference material workflows. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Small-Molecule Peptidomimetic Library SynthesisIn medicinal chemistry, lead discovery teams and CROs use Boc-L-3-Nitrophenylalanine for rapid assembly of peptidomimetic scaffolds, bioactive fragment libraries, and non-natural amino acid probes. Its electron-withdrawing nitro group modulates binding affinity and metabolic resistance in candidate hits. The Boc group ensures orthogonality, compatible with parallel or split-pool combinatorial synthesis, and enables iterative diversification workflows in high-throughput screening (HTS) campaigns. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Fluorogenic and Chromogenic Peptide Substrate ManufacturingProducers of biochemical assay tools employ Boc-L-3-Nitrophenylalanine in the synthesis of peptide substrates where enhanced UV-visible signal transduction or sterically-tuned reactivity is required. The nitro group at the meta position of the phenyl ring allows for sensitive detection in enzyme kinetic studies and cell-based screening platforms. During substrate synthesis, the Boc protection remains stable throughout orthogonal functionalization, supporting high lot-to-lot reproducibility as demanded in regulated diagnostics supply chains. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Boc-L-3-Nitrophenylalanine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Peptide synthesis thrives on reliability, purity, and smart protection strategies. As a long-standing manufacturer of fine chemicals and protected amino acids, we have learned that the details of molecular structure drive the success of each synthetic route. Boc-L-3-Nitrophenylalanine, featured in our product portfolio for years, has become a key option for researchers focused on introducing nitroaromatic functionality into peptide chains. Our experience tells us that the fusion of the Boc protecting group with the unique 3-nitro substitution opens possibilities that set this amino acid apart from standard derivatives.
A persistent demand for non-canonical amino acids does not mean any product will do. We differentiate ourselves by manufacturing Boc-L-3-Nitrophenylalanine at consistent high purity, routinely over 98%, based on our in-house protocols that emphasize detail at every step. The L-configuration and para-oriented nitro group play a crucial role in both the chemical reactivity and the behavior of the downstream peptides.
Our process for introducing the 3-nitro group relies on an electrophilic aromatic nitration under strictly controlled temperature and stoichiometry. Year after year, this yields a product free from ortho and para nitro-isomer contamination. The selective protection of the alpha-amino group with tert-butoxycarbonyl (Boc) shields the amine from unwanted reactions, reducing racemization during synthesis. Users often remark on the clean coupling reactions and reproducible yields, saving them time on purification and troubleshooting.
In our decades supplying amino acid derivatives, we have seen Boc-L-3-Nitrophenylalanine emerge as a go-to material for the synthesis of peptides where electron-deficient aromatic rings are needed. The nitro group at the meta position tunes the reactivity of the aromatic system, supporting selective transformations downstream. Researchers have incorporated this amino acid for probing aromatic stacking interactions, for modifying biological activity, and as a marker for photophysical studies.
Scientific groups at academic and industrial labs frequently order this product for structure-activity relationship studies, where even subtle electronic changes result in meaningful biological data. Others leverage the ortho/para-directing influence of the nitro substituent for site-specific modifications or cross-coupling. The Boc group offers the flexibility of classical solution-phase as well as some solid-phase peptide synthesis strategies, depending on the pathway and choice of cleavage conditions. In hands-on production, we have seen researchers appreciate the sharp melting point and clear NMR spectra, which support rapid quality control in their own workflows.
Stability during storage and handling ranks just as high as high starting purity for demanding researchers. Early batches of Boc-L-3-Nitrophenylalanine highlighted the risk of hydrolysis and byproduct formation, prompting us to modify our packaging to use moisture-resistant liners and desiccant pouches. The compound remains solid under ambient conditions, but long-term users understand the importance of tightly sealing containers between uses, which keeps reactivity crisp for months.
Our technicians noticed, years ago, that the nitro group did not dramatically lower solubility compared to other aromatic amino acids. As a result, coupling reactions proceed efficiently without resorting to aggressive solvents or elaborate activation procedures. The Boc group comes off cleanly under acidic conditions without rearrangement, a property that helped several large-scale clients streamline their processes and reduce losses due to side reactions.
Many clients come to us with the question: Does it matter whether the nitro group sits in the 2-, 3-, or 4-position? From our direct experience in both production chemistry and supporting customer syntheses, the answer is unequivocal: Yes. The 3-nitro variant of phenylalanine significantly changes the electronic behavior of the aromatic ring without the same steric hindrance seen with ortho substitution.
Comparing Boc-L-3-Nitrophenylalanine to Boc-L-4-nitrophenylalanine, the reduced conjugation with the amino acid backbone in the meta isomer lowers the electron density at specific sites, which researchers use to effect regioselective modifications and to stabilize dimer interactions in structured peptides. The 2-nitro isomer, by contrast, increases the challenge of efficient coupling and can suppress reactivity enough to stall automated synthesizers. Direct substitution with electron-donating groups results in wholly different behavior: those derivatives provide little insight into nitro-driven conformational effects or photochemical responses.
Experienced peptide scientists recognize the Boc protection as a classic form that remains unmatched in selectivity for stepwise synthesis, especially where side-chain reactivity can otherwise lead to impurities. We routinely hear feedback from our users that switching from Fmoc- to Boc-protected nitrophenylalanine gives superior results for certain acidolytic cleavage protocols and streamlines purification, especially when working with hydrophobic sequences that resist traditional desalting.
Producing specialty amino acids at gram, multi-kilogram, and even higher scales tests more than just the upfront chemistry. Collecting feedback from medicinal chemists and peptide engineers, we learned years ago that consistent particle sizing and solvent content controls play a bigger role than most suppliers admit. Our continuous investment in crystallization optimization, vacuum drying, and real-time analytics has produced lot-to-lot uniformity that repeat clients rely on for process validation and regulatory filings.
We continue to develop process analytical technology (PAT) protocols, allowing real-time tracking of color, optical rotation, and purity. These have prevented bottlenecks on several large research projects where scale-up introduced subtle impurities that would rarely appear in bench-scale batches from academic sources. We recall a project in which a commercial customer, after switching to our material, reported a measurable reduction in time spent on HPLC purification due to a single-digit drop in byproduct formation. Our process control allowed them to divert resources to new analog development, instead of routine quality checks.
Peptide scientists rely on documented traceability and full analytical data. Each batch of Boc-L-3-Nitrophenylalanine comes with HPLC, NMR, and elemental analysis tracked from raw material sourcing to final packaging. Through long-term relationships with peptide research groups and pharmaceutical startups, we have adapted our documentation to satisfy not just research but also preclinical development standards. Audit trails matter more than ever as the move toward regulated therapeutic peptides accelerates.
In practice, this means we have built a feedback loop: customer-reported observations lead directly to adjustments in purification protocols and handling instructions. Every specification sheet is updated to reflect actual batch conditions, not generic data pulled from literature. Our laboratory keeps reference standards on hand to quickly resolve any anomalies in shipped product or analytical spectra.
Through years of hands-on manufacturing, we have learned that Boc-L-3-Nitrophenylalanine poses no unusual toxicity risk compared to other protected phenylalanine derivatives, but some care remains warranted. Crystal dust can irritate the respiratory tract, so we advise using a fume hood or suitable mask during weighing in both research and scale-up settings. The stability of the nitro group under reasonable handling means that decomposition does not pose a storage hazard, as long as the material is kept dry and out of direct sunlight.
Operators in our facilities have reported that the bulk powder has little tendency to clump, making it easy to portion for both gram- and kilogram-quantity shipments. Its resistance to static attraction improves transfer efficiency and cleanup. Waste generated from processing often contains trace amounts of nitro-aromatic byproducts, which follow local chemical waste disposal guidelines.
We continuously look for ways to refine both product and process, shaped by accounts from peptide chemists using Boc-L-3-Nitrophenylalanine in both small-molecule conjugates and full-length peptides. One client working with novel diagnostic agents reported higher labeling yields when using the meta-nitro derivative as a precursor, owing to its specific ring activation properties. Others have detailed the utility of the compound during cyclization steps, where the electronic effect of the nitro group facilitates unusually efficient ring closure.
Difficulties encountered in early adoption, such as poor solubility in polar organic solvents or unexpected byproduct formation under extended heating, have informed both our synthetic and customer support practices. Technical specialists in our team often review project reports in order to provide case-specific troubleshooting and to suggest modifications to coupling protocols, solvent systems, or deprotection steps. We publish regularly on process improvements and have supported client-led publications that reference our batch numbers, underpinning confidence in data reproducibility.
The increased scrutiny on nitroaromatic derivatives has changed the way chemical manufacturers handle production, storage, and documentation. Boc-L-3-Nitrophenylalanine does not fall under particular restriction lists in main jurisdictions, but we stay ahead by controlling emissions and monitoring for residual organic solvents. Our solvent recovery systems have achieved near-complete capture for commonly used chlorinated and polar aprotic solvents, reducing environmental impact by an order of magnitude compared to conventional batch synthesis.
We regularly work with clients securing material for later clinical development, and our internal documentation aligns with traceability requirements laid out by both regulatory and voluntary quality assurance organizations. As a manufacturer with a stake in both research and commercial supply, nothing tests a process like the need to comply with an external sustainability audit or a multi-country shipment with diverse documentation needs. We believe our ability to provide prompt, complete supporting material stems from hands-on participation in every link of the production and packaging chain.
Not every amino acid supplier understands the challenges involved in protected, functionally complex products. By investing in analytical infrastructure, process refinement, and direct client engagement, we have seen Boc-L-3-Nitrophenylalanine rise from a niche curiosity to a staple for innovation in peptide chemistry. Our daily work balances consistency—batch after batch of reproducible, analytically backed material—with adaptability to unique user needs.
As peptide therapeutics, diagnostic agents, and engineered protein scaffolds move into new territory, the need for specialty amino acids with tailored functional groups only intensifies. We see Boc-L-3-Nitrophenylalanine as an example where manufacturing know-how intersects with real-world scientific progress. From supporting first-time users with practical tips to solving synthesis issues at kilogram scale, the lessons learned in production translate into better data, lower cost per project cycle, and a deeper reservoir of technical know-how for future developments.
The landscape of custom amino acid manufacture has changed, but the fundamentals remain: purity, consistency, and trust in the supply chain remain at the center of high-value research. Boc-L-3-Nitrophenylalanine continues to validate its role as a key enabler for sophisticated synthesis projects. As our customers continue to push boundaries in molecular design, we remain committed to improving product quality through tight process control, ongoing technical dialogue, and a readiness to adapt to both small-scale prototyping and full-scale manufacturing projects.
In challenging chemical manufacturing environments, details matter. Our experience has shown that a focus on getting the chemistry right at the ground level—fresh raw materials, detailed process records, responsive customer support, and practical advice driven by actual use cases—produces more than just numbers on a certificate of analysis. Each container of Boc-L-3-Nitrophenylalanine leaving our facility carries with it the accumulated expertise of years spent refining each step from synthesis through application, and we continue to learn as our collaborators bring the product to new fields and new challenges.